期刊文献+

49例睾丸癌患者的临床特点及诊疗 被引量:3

Clinical characteristics and treatment of 49 cases of testicular cancer
下载PDF
导出
摘要 目的探讨睾丸癌患者的临床特点及诊疗。方法回顾性分析北京大学肿瘤医院泌尿外科行手术治疗的49例睾丸癌患者的临床资料。结果49例患者中,术前甲胎蛋白(AFP)升高11例,均≤44岁;人体绒毛膜促性腺激素(β-hCG)升高21例,其中19例≤44岁;乳酸脱氢酶(LDH)升高20例,其中18例≤44岁。术后2周AFP异常2例,均≤44岁;β-hCG异常6例,其中5例≤44岁;LDH均正常。49例患者均行睾丸癌根治术,其中6例行腹膜后淋巴结清扫术,23例患者术后行放射治疗/化学治疗。结论AFP、β-hCG和LDH对<45岁睾丸癌患者诊断和评估意义更大。需要开发具有更高灵敏度和特异性的标志物。腹膜后淋巴结清扫可以作为临床初始治疗。 Objective To explore the clinical characteristics and treatment outcome of testicular cancer.Methods To review retrospectly the clinical data of 49 patients who were diagnosed with testicular cancer and treated with operation in the Urology Department of Peking University Cancer Hospital.Results Among the 49 patients,11 had elevated preoperative alpha fetal protein(AFP)levels,all have the age as≤44 years;21 had elevatedβ-human chorionic gonadotropin(β-hCG)level,including 19 cases with age as≤44 years;20 had elevated lactate dehydrogenase(LDH),including 18 cases with the age as≤44 years.Two weeks after operation,there were 2 cases of abnormal AFP,both≤44 years old;6 cases of abnormalβ-hCG,including 5 cases≤44 years old;LDH were all normal.All patients underwent radical resection of testicular cancer,including 6 patients with retroperitoneal lymph node dissection(RLND),and 23 patients with postoperative radiotherapy/chemotherapy followed.Conclusions The significance of AFP,β-hCG and LDH is greater for the diagnosis and evaluation of patients<45 years old.Markers with higher sensitivity and specificity are needed for evaluation.RLND can be an option for initial treatment.
作者 梅儒齐 MEI Ru-qi(Department of Intensive Care,Peking University Cancer Hospital,Beijing 100142,China)
出处 《基础医学与临床》 2021年第6期881-884,共4页 Basic and Clinical Medicine
关键词 睾丸癌 肿瘤标志物 睾丸癌根治术 testicular cancer tumor biomarkers radical testicular cancer
  • 相关文献

参考文献2

二级参考文献8

  • 1van Heyningen V, Hoovers JM, de Kraker J, et al. Raised risk of Wilms tumour in patients with aniridia and submicroscopic WT1 deletion [ J ]. J Med Genet, 2007, : 787 - 790.
  • 2Bastacky S, Cieply K, Sherer C, et al. Use of interphase fluorescence in situ hybridization in prostate needle biopsy specimens with isolated high-grade prostatic intraepithelial neoplasia as apredictor of prostate adenocarcinoma on fol- low-up biopsy [J]. Hum Pathol, 2004, 35:281 -289.
  • 3Karnwal A, Venegas R, Shuch B, et al. The role of fluo- rescence in situ hybridization assay for surveillance of non- muscle invasive bladder cancer [J]. Can J Urol, 2010,17: 5077 - 5081.
  • 4Reid-Nicholson, Ramalingam P, Adeagbo B, et al. The use of Urovysion fluorescence in situ hybridization in the di- agnosis and surveillance of non-urothelial carcinoma of the bladder [ J ]. Mod Pathol, 2009,22 : 119 - 127.
  • 5Schrock E, Padilla-Nash H. Spectral karyotyping and mul- ticolor fluorescence in situ hybridization reveal new tumor- specific chromosomal aberrations [ J ]. Semin Hematol, 2000,37:334 - 347.
  • 6Kjellman M, Kallioniemi OP, Karhu R, et al. Genetic ab- errations in adrenocortical tumors detected using compara- tive genomic hybridization correlate with tumor size and ma- lignancy [J]. Cancer Res, 1996,56:4219 -4223.
  • 7Gunawan B, Huber W, Holtrup M, et al. Prognostic im- pact of cytogenetic findings in clear cell carcinoma: gain of 5q31 -qter predicts a distinct clinical phenotype with fa- vorable prognosis [ J ]. Cancer Res, 2001,61 : 7731 - 7738.
  • 8Nagy A, Buzogany I, Kovacs G. Microsatellite allelotyping differentiates chromophobe renal cell carcinomas from renal oncocytomas and identifies new genetic changes [ J ]. His- topathology, 2004,44 : 542 - 546.

共引文献5

同被引文献5

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部